Adiponectin predicts 5-year all cause in patients with symptomatic peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) study

被引:0
|
作者
Dieplinger, B. [1 ]
Gegenhuber, A. [2 ]
Poelz, W. [3 ]
Haltmayer, M. [1 ]
Mueller, T. [1 ]
机构
[1] Konvent Hosp Barmherzige Brueder, Linz, Austria
[2] Krankenhaus Bad Ischl, Bad Ischl, Austria
[3] Univ Linz, A-4040 Linz, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [31] Prognosis of patients with asymptomatic versus symptomatic peripheral arterial disease (PAD): 3-year results of the get ABI study
    Diehm, Curt
    Trampisch, Hans-Joachim
    Haberl, Roman
    Darius, Harald
    Mahn, Matthias
    Pittrow, David
    Tepohl, Gerhart
    Holland-Letz, Tim
    Allenberg, Jens-Rainer
    VASCULAR MEDICINE, 2007, 12 (02) : 141 - 141
  • [32] C-REACTIVE PROTEIN PREDICTS PROGRESSION OF PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH TYPE 2 DIABETES: A 5-YEAR FOLLOW-UP STUDY
    Popovic, Ljiljana
    Lalic, Katarina
    Vasovic, Olga
    Radojkovic, Danijela Draskovic
    Rajkovic, Natasa
    Singh, Sandra
    Stosic, Ljubica
    Civcic, Miodrag
    Hinic, Ljiljana Skoric
    Vujic, Tatiana Petrovic
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2014, 33 (04) : 347 - 355
  • [33] Peripheral Arterial Disease as an Independent Predictor for Excess Stroke Morbidity and Mortality in Primary-Care Patients: 5-Year Results of the getABI Study
    Meves, Saskia H.
    Diehm, Curt
    Berger, Klaus
    Pittrow, David
    Trampisch, Hans-Joachim
    Burghaus, Ina
    Tepohl, Gerhart
    Allenberg, Jens-Rainer
    Endres, Heinz G.
    Schwertfeger, Markus
    Darius, Harald
    Haberl, Roman L.
    CEREBROVASCULAR DISEASES, 2010, 29 (06) : 546 - 554
  • [34] Serum creatinine predicts all-cause and cardiovascular mortality in patients with peripheral arterial disease: The role of antiplatelet treatment
    Pasqualini, L.
    Gemelli, F.
    Vaudo, G.
    Mannarino, M. R.
    Innocente, S.
    Schillaci, G.
    Mannarino, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 102 - 103
  • [35] Impact of peripheral arterial disease in patients with diabetes: Results from PROactive
    Dormandy, John A.
    Betteridge, John
    Schernthaner, Guntram
    Pirags, Valdis
    Norgren, Lars
    DIABETES, 2008, 57 : A86 - A86
  • [36] PATIENTS WITH DIABETES AND PERIPHERAL ARTERIAL DISEASE: RESULTS FROM THE EXSCEL TRIAL
    Badjatiya, Anish
    Merrill, Peter
    Buse, John
    Goodman, Shaun
    Katona, Brian
    Iqbal, Nayyar
    Ohman, Peter
    Pagidipati, Neha
    Sattar, Naveed
    Holman, Rury
    Hernandez, Adrian
    Mentz, Robert J.
    Patel, Manesh
    Jones, Schuyler
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2040 - 2040
  • [37] Bisphenol A and Peripheral Arterial Disease: Results from the NHANES
    Shankar, Anoop
    Teppala, Srinivas
    Sabanayagam, Charumathi
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2012, 120 (09) : 1297 - 1300
  • [38] Adiponectin level predicts development of peripheral arterial disease in subjects with type 2 diabetes
    Jiang, YD
    Tai, TY
    Chang, CC
    Chen, THH
    Chuang, LM
    DIABETES, 2004, 53 : A94 - A94
  • [39] Prevalence and Prediction of Previously Unrecognized Peripheral Arterial Disease in Patients With Coronary Artery Disease: The Peripheral Arterial Disease in Interventional Patients Study
    Moussa, Issam D.
    Jaff, Michael R.
    Mehran, Roxana
    Gray, William
    Dangas, George
    Lazic, Zoran
    Moses, Jeffery W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (06) : 719 - 724
  • [40] Adiponectin level predicts development of peripheral arterial disease in subjects with type 2 diabetes
    Jiang, YD
    Tai, TY
    Chang, CC
    Chen, THH
    Chuang, LM
    DIABETES, 2004, 53 : A172 - A173